Scientific publications

Twists and turns to translating 4-1BB cancer immunotherapy. Scientific Publication

Jun 12, 2019 | Magazine: Science Translational Medicine

Miguel F Sanmamed, Iñaki Etxeberría, Itziar Otano, Ignacio Melero

Abstract

Previous shortcomings of CD137-targeted immunotherapy may be overcome by engineered bispecific agents (Claus et al, this issue).

CITATION Sci Transl Med. 2019 Jun 12;11(496):eaax4738. doi: 10.1126/scitranslmed.aax4738.

see publication in pubmed

Our authors

Imagen del Dr. Miguel Fernández de Sanmamed Gutiérrez, Investigador principal del grupo Onco-Inmunología Aplicada y Traslacional de la Clínica Universidad de Navarra
Dr. Miguel Fernández de Sanmamed Gutiérrez Curriculum
Specialist Medical Oncology Department
Navarre headquarters
Imagen del Dr. Ignacio Melero Bermejo, especialista en Inmunología de la Clínica Universidad de Navarra.
Dr. Ignacio Melero Bermejo Curriculum
Codirector Immunology and Immunotherapy Department
Navarre headquarters